Core Viewpoint - Avalon GloboCare Corp. has entered into a definitive agreement with Qi Diagnostics Limited to co-develop a VOC nanosensor-based point-of-care cannabis breathalyzer aimed at enhancing public safety and supporting real-time detection of cannabis-impaired driving [1][2][3] Company Overview - Avalon GloboCare Corp. (NASDAQ: ALBT) specializes in precision diagnostic consumer products and is advancing intellectual property in cellular therapy [4] - The company is currently marketing the KetoAir™ breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device [4] Strategic Collaboration - The collaboration involves Avalon, its subsidiary Q&A Distribution, LLC, and Qi Diagnostics to jointly design, validate, and develop a prototype for the cannabis breathalyzer device [2] - This partnership aims to combine Avalon's regulatory expertise with Qi Diagnostics' VOC nanosensor technology to provide a non-invasive cannabis detection solution [3]

Core Viewpoint - Avalon GloboCare Corp. and YOOV Group Holding Limited have announced a proposed merger, aiming to create a publicly-traded company focused on AI-driven business automation solutions [1][2]. Company Overview - Avalon GloboCare Corp. is a commercial-stage company specializing in precision diagnostic consumer products and cellular therapy, currently marketing the KetoAir™ breathalyzer device, which is registered as a Class I medical device with the U.S. FDA [6]. - YOOV Group Holding Limited is an AI-as-a-Service platform that specializes in intelligent business automation, allowing businesses to optimize operations without extensive resources or technical expertise [4]. Merger Details - The merger involves Nexus MergerSub Limited, a wholly owned subsidiary of Avalon, merging with YOOV, with YOOV becoming a wholly owned subsidiary of Avalon [2]. - The merger is subject to stockholder approval from Avalon and the Nasdaq Stock Market's approval for YOOV's listing post-merger [3]. Additional Offerings - YOOV extends its services into financial and insurance sectors through subsidiaries YOOV Capital Limited and YOOV Insurance Services Limited, enhancing its ecosystem with credit evaluation and insurance brokerage services [5].

Company Overview - Avalon GloboCare Corp. has entered into a definitive merger agreement with YOOV Group Holding Limited, a provider of AI automation solutions, with the combined company expected to operate under the name YOOV, Inc. and trade on Nasdaq under the symbol "YOOV" [1][5] - The merger is anticipated to close in the third quarter of 2025, subject to stockholder approval and other customary closing conditions [5][6] Financial Performance - YOOV reported unaudited revenue of $45.7 million and net income of $3.4 million for the calendar year 2024, marking a 59.1% increase in revenue compared to $28.7 million and a net loss of $2.4 million in 2023 [1][3] - For the fiscal year ending March 31, 2024, YOOV had unaudited revenue of $29.6 million and net income of $1.3 million, compared to $21.5 million in revenue and a net loss of $527,403 for the fiscal year ending March 31, 2023 [3] Strategic Rationale - The merger is viewed as a strategic opportunity to unlock value and drive innovation in AI-driven automation, with both companies expressing confidence in the potential for long-term shareholder value [4][6] - YOOV's AIaaS platform is designed to enhance operational efficiency and productivity for businesses of all sizes, emphasizing scalability and flexibility [2][9] Management Structure - Post-merger, Phil Wong will serve as Chairman, CEO, and President of the combined company, with a board of directors consisting of seven members, five from YOOV and two from Avalon [6]